NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 37,960 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
37,960 Papers indexed
963 Papers AI scored
37,960 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-09-10 09:15 AM
1 CART-Cell Therapy in Pediatric Acute Lymphoblastic Leukemia: A Review for General Pediatricians. Pediatrics 74.02 Sep 10, 2026 2 Solid tumours in RASopathies: insights from a large monocentric cohort and systematic review of the literature. Journal of medical genetics 70.0 Sep 10, 2026 3 Biopsychosocial Antecedents and Symptom Burden Among Children Undergoing Cancer Treatment: A Systematic Review. Journal of pain and symptom management 79.94 Sep 10, 2026 4 Cerebrospinal Fluid Shunt Failure in Children Is Associated with Medical Complexity and Shunt Position, Not Shunt Technology: A Multicenter Prospective Study from the Hydrocephalus Clinical Research Network. The Journal of pediatrics 72.5 Sep 10, 2026 5 Response-adapted inotuzumab ozogamicin in paediatric first-relapse B-cell acute lymphoblastic leukaemia - Authors' reply. The Lancet. Haematology 50.74 Sep 10, 2026 6 Response-adapted inotuzumab ozogamicin in paediatric first-relapse B-cell acute lymphoblastic leukaemia. The Lancet. Haematology 50.74 Sep 10, 2026 7 Usability Across 3 mHealth Problem-Solving Training Interventions for Diverse Neurodevelopmental and Neurological Populations: Multicase Usability Evaluation. JMIR human factors 61.2 Sep 10, 2026 8 Real-World Efficacy and Safety of Tyrosine Kinase Inhibitors in Patients With Advanced Bone Sarcomas: The TOGBONE Study of the Turkish Oncology Group. JCO global oncology 83.36 Sep 10, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

37960 results
C
A Model-Informed Early Prediction of Methotrexate-Induced Acute Kidney Injury in Pediatric Patients with Osteosarcoma Using Real-World Data: A Multi-center Pharmacokinetic Study.
PMID 42243443 Published: 2026-06-04 Ingested: 2026-08-02 12:07 AM Clinical pharmacokinetics
AI -
Base 68.3
Rank 68.3
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 68.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 64.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
The Landscape of Pediatric Differentiated Thyroid Carcinoma and Predictors of Invasive Disease: A CATC Study.
PMID 42025318 Published: 2026-04-22 Ingested: 2026-08-02 12:06 AM The Journal of clinical endocrinology and metabolism
AI -
Base 68.3
Rank 68.3
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 68.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 80.0; recency: 100.0; abstract quality: 100.0.

C
Twelve-year utilization and outcomes of haploidentical hematopoietic stem cell transplantation (HSCT) in the Eastern Mediterranean (EM) region: A multicenter EMBMT registry analysis.
PMID 41922739 Published: 2026-04-01 Ingested: 2026-08-02 12:06 AM Bone marrow transplantation
AI -
Base 68.3
Rank 68.3
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 68.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 80.0; recency: 100.0; abstract quality: 100.0.

C
Cumulative sociodemographic risk moderates the short-term effects of active music engagement.
PMID 41863346 Published: 2026-05-01 Ingested: 2026-08-02 12:07 AM Journal of pediatric psychology
AI -
Base 68.3
Rank 68.3
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 68.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 44.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.

C
Epilepsy in pediatric patients with PTEN hamartoma tumor syndrome: First step in recommendations for clinical management.
PMID 41825102 Published: 2026-03-09 Ingested: 2026-08-02 12:06 AM European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
AI -
Base 68.3
Rank 68.3
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 68.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 44.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.

C
Multiclass Radiomics-Based Prediction of BRAF Mutation Status in Pediatric Low-Grade Gliomas Using Multisequence MRI.
PMID 41819797 Published: 2026-03-17 Ingested: 2026-08-02 12:06 AM AJNR. American journal of neuroradiology
AI -
Base 68.3
Rank 68.3
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 68.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 80.0; recency: 100.0; abstract quality: 100.0.

C
First 2-year experience of nationwide newborn screening for severe forms of T and B cell immunodeficiency: 2.3 million newborns analyzed using TREC and KREC in Russia.
PMID 41727503 Published: 2026-02-06 Ingested: 2026-08-02 12:06 AM Frontiers in immunology
AI -
Base 68.3
Rank 68.3
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 68.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 44.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.

C
[Clinical efficacy analysis of seven pediatric patients with Acute myeloid leukemia and the t(16;21)(p11;q22) FUS::ERG fusion gene].
PMID 41663298 Published: 2026-02-10 Ingested: 2026-08-02 12:06 AM Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
AI -
Base 68.3
Rank 68.3
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 68.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 64.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Patient Concerns on Access to Supportive Care Medicines and Symptom Management Outcomes Among Children with Cancer in Tanzania.
PMID 41662216 Published: 2026-02-09 Ingested: 2026-08-02 12:06 AM Journal of pediatric hematology/oncology nursing
AI -
Base 68.3
Rank 68.3
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 68.3/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 44.0; sample size: 60.0; recency: 100.0; abstract quality: 85.0.

Previous
Page 752 of 3164
Next
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic